EPYSQLI 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

Samsung Bioepis Nl B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 6c8476f5a3f000d1
Drug Cima Aemps Name: EPYSQLI 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1231735001
Holder Company Name: Samsung Bioepis Nl B.V.
Marketing Company Name: Samsung Bioepis Nl B.V.
Holder Company Detail Path: /organization/samsung-bioepis-nl-b-v
Marketing Company Detail Path: /organization/samsung-bioepis-nl-b-v
Authorization Date: 2023-06-20
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 300 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Samsung Bioepis Nl B.V.
Company Detail Path: /organization/samsung-bioepis-nl-b-v

ECULIZUMAB

300 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 20, 2023

Approval ID

6c8476f5a3f000d1

Type

Standard